SXI Life Sciences
7.548,55
PKT
-6,03
PKT
-0,08
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.09.05 | Novartis halten | Wertpapier | |
| 09.09.05 | Novartis hold | Deutsche Bank | |
| 09.09.05 | Novartis buy | A.G. Edwards & Sons | |
| 08.09.05 | Novartis Buy | AG Edwards | |
| 05.09.05 | Novartis | Weberbank | |
| 02.09.05 | Novartis average | Caris & Company | |
| 02.09.05 | Novartis akkumulieren | Independent Research | |
| 05.09.05 | Novartis Average | Caris & Company | |
| 01.09.05 | Novartis halten | National-Bank AG | |
| 01.09.05 | Novartis buy | Merrill Lynch | |
| 01.09.05 | Novartis hold | SEB | |
| 31.08.05 | Novartis peer perform | Thomas Weisel Partners | |
| 31.08.05 | Novartis Outperform | Wachovia Sec | |
| 31.08.05 | Novartis Peer Perform | Thomas Weisel Partners | |
| 29.08.05 | Novartis outperform | WestLB | |
| 26.08.05 | Novartis halten | National-Bank AG | |
| 25.08.05 | Straumann | Focus Money | |
| 17.08.05 | Novartis kaufen | Helaba Trust | |
| 10.08.05 | Novartis | Weberbank | |
| 09.08.05 | Novartis neutral | Nasd@q Inside | |
| 09.08.05 | BB Biotech kaufen | Hamburger Sparkasse | |
| 04.08.05 | Lonza halten | Hamburger Sparkasse | |
| 28.07.05 | Novartis buy | Merrill Lynch | |
| 21.07.05 | Novartis halten | National-Bank AG | |
| 21.07.05 | Novartis | Zürcher Kantonalbank | |
| 21.07.05 | BB Biotech | Wirtschaftswoche | |
| 21.07.05 | Novartis Net Negative | Susquehanna Financial | |
| 20.07.05 | Novartis buy | Banque SYZ & CO | |
| 20.07.05 | Novartis | JRC | |
| 18.07.05 | Novartis buy | Merrill Lynch | |
| 15.07.05 | Novartis kaufen | Hamburger Sparkasse | |
| 15.07.05 | Novartis kaufen | National-Bank AG | |
| 15.07.05 | Novartis akkumulieren | Independent Research | |
| 19.07.05 | Novartis buy | Jyske Bank | |
| 14.07.05 | Novartis kaufen | Helaba Trust | |
| 14.07.05 | Novartis buy | SEB | |
| 14.07.05 | Novartis akkumulieren | Independent Research | |
| 13.07.05 | Novartis neutral | HypoVereinsbank | |
| 13.07.05 | Novartis outperform | Bear Stearns | |
| 12.07.05 | Novartis kaufen | Helaba Trust |